Evidence map›Paper›PMID 42591218›Full record

ArticleFrontiers in digital health2026

Development of an AI-driven chatbot for medication-assisted treatment standards in Scotland.

Sandra C Nwobi, Zainab Loukil, Abbas Jawahar

Abstract read
In one paragraph

Article in Frontiers in digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sandra C NwobiSchool of Business, Computing and Social Sciences, University of Gloucestershire, Cheltenham, United Kingdom.
Zainab LoukilCyber and Technical Computing, School of Business, Computing and Social Sciences, University of Gloucestershire, Cheltenham, United Kingdom.
Abbas JawaharSchool of Business, Computing and Social Sciences, University of Gloucestershire, Cheltenham, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Scotland faces a severe public health crisis with drug-related deaths reaching 267 per million people, ranking second globally after the United States. Medication-Assisted Treatment (MAT) represents a proven intervention for heroin addiction. However, healthcare professionals struggle with accessing and interpreting current MAT standards through fragmented information systems and time-consuming manual searches across multiple websites. Despite advances in healthcare chatbots leveraging Large Language Models (LLMs), no specialized systems exist to support MAT delivery or integrate advanced technologies like Retrieval-Augmented Generation (RAG) and Knowledge Graphs for addiction treatment. Objective: To develop and evaluate an AI-driven chatbot prototype that integrates LLMs, RAG, and Knowledge Graphs to enhance healthcare professionals' access to MAT standards in Scotland, addressing current barriers in information delivery and clinical decision-making. Methods: We employed a mixed-methods approach combining a survey of 39 MAT healthcare professionals (31% response rate) and systematic literature review following PRISMA guidelines. The chatbot prototype was developed using Llama2 language model, Neo4j knowledge graphs, and custom RAG implementation. Data was ethically collected from Public Health Scotland and Healthcare Improvement Scotland websites. Performance was evaluated using BLEU and ROUGE metrics, with prototype deployment via Streamlit interface. Results: Survey findings revealed significant challenges with current communication methods: only 5 of 39 respondents rated existing systems as "exceptional," while 17 rated them as "average" or below. Primary challenges included decentralized information ( Conclusions: To our knowledge, this study provides the first prototype of an AI-driven chatbot specifically designed for MAT professionals, demonstrating feasibility of integrating advanced AI technologies to address information access barriers in addiction treatment. While performance metrics indicate potential for enhancing MAT information delivery, further development is needed to improve semantic understanding and response naturalness. The prototype establishes a foundation for future integration with electronic health records and broader healthcare systems, with the potential to support improved treatment outcomes for individuals with heroin addiction in Scotland, subject to longitudinal clinical validation.

Indexed as

Artificial intelligence in healthcarehealthcare chatbotKnowledge Graphs (KGs)Large Language Models (LLMs)Medication-Assisted Treatment (MAT)opioid use disorderRetrieval-Augmented Generation (RAG)Scotland

Identifiers

PMID42591218
PMCPMC13461545

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.